GlassScriptPhysician profile
Gregory Y Kame
NPI 1518938307
$10,011.18
in general payments reported to CMS, 2019-2025
16 companies · $779 in 2025
The $779 reported for 2025 was more than what 82% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
See the full distribution for Corneal and Contact Management
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,760 · 2020: $4,069 · 2021: $583 · 2022: $1,229 · 2023: $1,273 · 2024: $318 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,907 · Entertainment: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,907.14 |
| Entertainment | $463.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $5,267.92 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Paragon Crt |
| Johnson & Johnson Vision Care, INC. | $1,129.08 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $971.78 | 2022-2025 | Total30, Dailies Total1, Precision 1 |
| Optos, INC. | $846.26 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $589.18 | 2019-2021 | |
| Maculogix, INC. | $303.27 | 2019 | |
| Bausch & Lomb Americas INC. | $255.26 | 2022-2023 | Infuse |
| Tarsus Pharmaceuticals, INC. | $179.48 | 2024-2025 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $147.89 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $132.46 | 2019-2020 | |
| Shire North American Group INC | $75.06 | 2019 | |
| Carl Zeiss Meditec, INC. | $34.48 | 2020 | |
| Visioneering Technologies, INC. | $26.73 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Abbvie INC. | $19.29 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $13.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Kame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.